Literature DB >> 25736327

Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria.

Ekaterina Tiourin1, Victor S Velasco1, Miguel A Rosales1, Peggy S Sullivan2, Deanna M Janzen1, Sanaz Memarzadeh3.   

Abstract

Tubal ligation keeps the fimbriated end of the fallopian tube intact while interrupting the conduit for sperm and egg between the uterus and ovary. Tubal ligation is associated with an approximately 20% decreased risk of high-grade serous ovarian cancers, which mounting evidence suggests arise from the distal fallopian tube epithelium. We postulated that biological changes at the epithelial cellular level of the distal fallopian tube may account for the surgical procedure's observed risk reduction. We compared the histology, presence of epithelial progenitors (basally located CD44-positive cells), and degree of epithelial proliferation (Ki67-positive cells) of distal fallopian tube from 10 patients with previous tubal ligation and 10 age-matched patients with uncut fallopian tubes. A significantly reduced population of proliferating epithelial progenitors (basally located CD44/Ki67 dual-positive cells) was detected in the tubal ligated specimens (P = .0002). To functionally assess the effect of tubal ligation, a murine model was utilized to compare the growth capacity of distal fallopian tube epithelial cells isolated from either ligated or sham-operated tubal epithelia. Murine fallopian tube epithelial cells isolated after tubal ligation showed a significantly reduced capacity to grow organoids in culture compared to sham-operated controls (P = .002). The findings of this study show that tubal ligation is associated with a reduced presence and decreased proliferation of progenitor cells in the distal fallopian tube epithelium. These compositional and functional changes suggest that tubal ligation induces quiescence of distal fallopian tube epithelial cells.
© The Author(s) 2015.

Entities:  

Keywords:  fallopian epithelial progenitors; fallopian tube epithelial proliferation; tubal ligation

Mesh:

Substances:

Year:  2015        PMID: 25736327      PMCID: PMC5933088          DOI: 10.1177/1933719115574345

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  43 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissues.

Authors:  M C Roach; V L Boucher; C Walss; P M Ravdin; R F Ludueña
Journal:  Cell Motil Cytoskeleton       Date:  1998

3.  Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

Authors:  Nathan J Bowen; Sanjay Logani; Erin B Dickerson; Laura B Kapa; Mariam Akhtar; Benedict B Benigno; John F McDonald
Journal:  Gynecol Oncol       Date:  2006-10-24       Impact factor: 5.482

4.  Morphology and ultrastructure of fallopian tube epithelium at different stages of the menstrual cycle and menopause.

Authors:  J Crow; N N Amso; J Lewin; R W Shaw
Journal:  Hum Reprod       Date:  1994-12       Impact factor: 6.918

Review 5.  Underlying mechanisms of ovarian cancer risk reduction after tubal ligation.

Authors:  David Cibula; Martin Widschwendter; Michael Zikan; Ladislav Dusek
Journal:  Acta Obstet Gynecol Scand       Date:  2011-04-15       Impact factor: 3.636

6.  Laparoscopic tubal anastomosis.

Authors:  S C Ribeiro; R A Tormena; C G Giribela; C R Izzo; N C Santos; J A Pinotti
Journal:  Int J Gynaecol Obstet       Date:  2004-02       Impact factor: 3.561

7.  Vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) immunoreactivities in rat ovaries and uterine tubes after tubal ligation: a controlled immunohistochemical study.

Authors:  Sevtap Kilic; Nicel Tasdemir; Nese Lortlar; Beril Yuksel; Gurer Budak; Sertac Batioglu
Journal:  Eur J Contracept Reprod Health Care       Date:  2008-12       Impact factor: 1.848

8.  Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Authors:  Weiva Sieh; Shannon Salvador; Valerie McGuire; Rachel Palmieri Weber; Kathryn L Terry; Mary Anne Rossing; Harvey Risch; Anna H Wu; Penelope M Webb; Kirsten Moysich; Jennifer A Doherty; Anna Felberg; Dianne Miller; Susan J Jordan; Marc T Goodman; Galina Lurie; Jenny Chang-Claude; Anja Rudolph; Susanne Krüger Kjær; Allan Jensen; Estrid Høgdall; Elisa V Bandera; Sara H Olson; Melony G King; Lorna Rodriguez-Rodriguez; Lambertus A Kiemeney; Tamara Marees; Leon F Massuger; Anne M van Altena; Roberta B Ness; Daniel W Cramer; Malcolm C Pike; Celeste Leigh Pearce; Andrew Berchuck; Joellen M Schildkraut; Alice S Whittemore
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

9.  Pregnancy following tubocornual anastomosis.

Authors:  G Lavy; M P Diamond; A H DeCherney
Journal:  Fertil Steril       Date:  1986-07       Impact factor: 7.329

10.  Identification of quiescent, stem-like cells in the distal female reproductive tract.

Authors:  Yongyi Wang; Andrea Sacchetti; Matthijs R van Dijk; Marten van der Zee; Paul H van der Horst; Rosalie Joosten; Curt W Burger; J Anton Grootegoed; Leen J Blok; Riccardo Fodde
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more
  1 in total

1.  Cellular heterogeneity of human fallopian tubes in normal and hydrosalpinx disease states identified using scRNA-seq.

Authors:  Nicole D Ulrich; Yu-Chi Shen; Qianyi Ma; Kun Yang; D Ford Hannum; Andrea Jones; Jordan Machlin; John F Randolph; Yolanda R Smith; Samantha B Schon; Ariella Shikanov; Erica E Marsh; Richard Lieberman; Stephen J Gurczynski; Bethany B Moore; Jun Z Li; Sue Hammoud
Journal:  Dev Cell       Date:  2022-03-22       Impact factor: 13.417

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.